Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT03854071 · Heart Failure, Pulmonary Hypertension, and more
NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more
NCT06899815 · Pulmonary Hypertension
NCT07462260 · Pulmonary Hypertension, Rheumatic Valvular Heart Disease
UCSF Health St. Mary's Hospital
San Francisco, California
Heart and Vascular Center
San Francisco, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions